Suyash Deodhar
About Suyash Deodhar
Suyash Deodhar is a scientist at Bristol Myers Squibb in New Brunswick, New Jersey, with a background in neuroscience and pharmaceutical sciences. He has held various research and leadership roles at institutions such as the University of Nebraska Medical Center and Creighton University.
Current Role at Bristol Myers Squibb
Suyash Deodhar is currently employed as a Scientist at Bristol Myers Squibb in New Brunswick, New Jersey. His responsibilities in this role involve working on a variety of scientific projects and contributing to the company's research and development efforts.
Previous Experience at University of Nebraska Medical Center
Suyash Deodhar served in multiple roles at the University of Nebraska Medical Center from 2019 to 2023. As President and Co-founder of the UNMC Consulting Club, he was instrumental in establishing and leading the club. He also worked as a Vice President Student Representative for the IGBPS Neuroscience Program and as a Graduate Research Assistant, conducting extensive research in neuroscience.
Educational Background
Suyash Deodhar holds a Doctor of Philosophy (PhD) in Neuroscience from the University of Nebraska Medical Center. He also earned a Master of Science in Pharmaceutical Sciences from Creighton University, along with a Bachelor’s Degree in Pharmacy from Savitribai Phule Pune University.
Research and Publications
Suyash Deodhar has contributed to the field of neuroscience and pharmaceutics through various research projects. He co-authored a research paper focusing on neuroinflammation in neurodegenerative diseases and presented his findings on advanced pharmaceutics at the American Association of Pharmaceutical Scientists (AAPS) annual meeting.
Awards and Recognitions
Throughout his academic and professional journey, Suyash Deodhar has received several accolades. Notably, he was honored with the 'Outstanding Graduate Student Award' from Creighton University for his exceptional research contributions. Additionally, he developed a novel drug delivery system during his time at Creighton University, which is currently under patent review.